SWLSX
Price
$39.93
Change
+$0.18 (+0.45%)
Updated
Jul 28 closing price
Net Assets
546.23M
VIGAX
Price
$234.68
Change
+$0.94 (+0.40%)
Updated
Jul 28 closing price
Net Assets
311.95B
Interact to see
Advertisement

SWLSX vs VIGAX

Header iconSWLSX vs VIGAX Comparison
Open Charts SWLSX vs VIGAXBanner chart's image
Schwab Large-Cap Growth
Price$39.93
Change+$0.18 (+0.45%)
VolumeN/A
Net Assets546.23M
Vanguard Growth Index Admiral
Price$234.68
Change+$0.94 (+0.40%)
VolumeN/A
Net Assets311.95B
SWLSX vs VIGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SWLSX vs. VIGAX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SWLSX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. SWLSX (546M). VIGAX pays higher dividends than SWLSX: VIGAX (0.45) vs SWLSX (0.00). SWLSX was incepted earlier than VIGAX: SWLSX (20 years) vs VIGAX (25 years). SWLSX (1.00) is less costly to investors than VIGAX (0.05). SWLSX is a more actively managed with annual turnover of: 15.00 vs. VIGAX (11.00). SWLSX has a lower initial minimum investment than VIGAX: SWLSX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 26.05 vs. SWLSX (23.16). VIGAX return over 5 years is better than : 113.30 vs. SWLSX (94.56).
SWLSXVIGAXSWLSX / VIGAX
Total Expense Ratio0.990.051,980%
Annual Report Gross Expense Ratio1.000.052,000%
Fund Existence20 years25 years-
Gain YTD11.35011.107102%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets546M312B0%
Annual Yield % from dividends0.000.45-
Returns for 1 year23.1626.0589%
Returns for 3 years73.5280.9791%
Returns for 5 years94.56113.3083%
Returns for 10 years124.10314.4439%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.510.10
+7.09%
PMV Pharmaceuticals
CSTM13.930.26
+1.90%
Constellium SE
CMPX3.200.02
+0.63%
Compass Therapeutics
ASND164.16-3.31
-1.98%
Ascendis Pharma A/S
ALZN2.77-0.19
-6.42%
Alzamend Neuro Inc.